# How do employers manage rising healthcare costs?

hcco.app · November 7, 2026

> Employers face unprecedented pressure as novel treatments introduce massive upfront costs into their benefit plans. Cell and gene therapies, while...

## Navigating Cell And Gene Therapy Expenses

Employers face unprecedented pressure as novel treatments introduce massive upfront costs into their benefit plans. Cell and gene therapies, while potentially curative, often carry price tags that strain traditional budgeting models. To manage these rising healthcare costs, organizations must shift from reactive claims processing to proactive care coordination. This requires robust data analytics to identify high-risk patients early and negotiate value-based contracts that align provider incentives with long-term outcomes. By leveraging specialized software platforms, employers can track treatment efficacy and ensure that expensive interventions are deployed only where they deliver measurable health improvements.

**Also worth reading:** [How to Manage Healthcare IT Integration During an M&A Deal?](https://hcco.app/knowledge/how_to_manage_healthcare_it_integration_during_an_ma_deal.php) · [What percentage of healthcare costs could be prevented?](https://hcco.app/knowledge/what_percentage_of_healthcare_costs_could_be_prevented.php) · [How can healthcare organizations effectively reduce costs without compromising patient care quality?](https://hcco.app/knowledge/how_can_healthcare_organizations_effectively_reduce_costs_without_compromising_patient_care_quality.php)

Simultaneously, collaboration between payers and providers becomes essential to navigate these financial complexities. Employers should engage with pharmacy benefit managers and healthcare networks to establish clear pathways for accessing these therapies while controlling overall spend. Implementing structured care coordination programs allows for better patient management, reducing the likelihood of costly complications that arise from fragmented care. Furthermore, continuous monitoring of utilization patterns helps identify inefficiencies before they escalate into significant financial burdens. This strategic approach not only addresses immediate cost concerns but also builds a sustainable framework for future healthcare expenditures, ensuring that employers can maintain financial stability while supporting their workforce’s health needs effectively.

## Leveraging PBM Negotiation Strategies

Employers increasingly rely on pharmacy benefit managers to translate purchasing scale into measurable savings without shifting all costs to employees. By negotiating rebates, preferred formularies, and utilization controls, they can steer spending toward clinically appropriate therapies while preserving access. Transparent contract terms, pass-through pricing, and regular audit rights help ensure savings reach the plan rather than disappearing into opaque spread pricing. For high-cost specialty drugs, employers can pair PBM negotiations with biosimilar adoption, site-of-care optimization, and adherence programs that reduce waste and prevent avoidable complications.

A disciplined approach also requires aligning incentives across HR, finance, and clinical teams so pharmacy strategy supports broader cost-containment goals. Employers should track total cost of care, not just drug spend, and use data to identify members who need care coordination before high-cost events occur. When PBM performance is measured against outcomes, employers can adjust benefit design, improve vendor accountability, and sustain affordable coverage amid rising healthcare prices.

## Implementing Payment Integrity Solutions

Employers often redesign benefits or shift costs to employees, yet a persistent gap remains in verifying that every healthcare dollar is spent accurately. Payment integrity addresses this by systematically reviewing claims before and after payment to catch billing errors, duplicate charges, and services that fall outside plan guidelines. For self-funded employers, even small error rates can translate into significant financial leakage, especially as high-cost treatments like cell and gene therapies become more common. Closing this gap requires more than periodic audits; it demands continuous oversight that aligns clinical data with billing rules.

Modern cost-containment platforms help payer and provider operations teams automate this process by flagging anomalies, validating coding accuracy, and coordinating follow-up with care teams. By integrating payment integrity into daily workflows, employers gain clearer visibility into where spending deviates from expectations and can recover overpayments before they compound. This approach not only protects plan assets but also supports fairer pricing and more sustainable benefits for employees over time.

## Utilizing Out Of Network Claims

One unresolved challenge for employers facing relentless healthcare cost growth is gaining visibility into out-of-network claims before they become budget-breaking surprises. These claims often stem from emergency care, specialist referrals, or gaps in network adequacy, and they frequently carry higher allowed amounts than in-network services. By reviewing claims data in near real time, employers and their plan administrators can spot patterns of leakage, flag high-cost episodes early, and intervene with members to redirect care to appropriate in-network providers when clinically feasible.

Platforms like hcco.app support this effort by connecting payer and provider operations through cost-containment and care-coordination workflows. When an out-of-network claim is detected, coordinated outreach can help resolve billing disputes, negotiate more reasonable rates, and guide members toward in-network follow-up care. This proactive approach reduces financial exposure, improves the member experience, and turns a reactive claims process into a strategic lever for managing overall plan spend while preserving access to necessary treatment.

## Strengthening State Price Containment

Employers increasingly find that market leverage alone cannot restrain hospital prices, so many are turning to state-level strategies that set enforceable guardrails around provider payment rates. Programs like the Peterson-Milbank initiative help states benchmark commercial insurance prices and cap growth, which indirectly shields self-insured employers who previously had little recourse against dominant hospital systems demanding double-digit annual increases. Where state benchmarks exist, employer coalitions can push regulators to enforce them more aggressively and close loopholes that allow outlier hospitals to negotiate around the caps.

Employers can also work within these frameworks by choosing benefit designs that steer members toward facilities complying with reasonable payment standards, and by supporting state legislation that increases transparency around negotiated rates. While state price containment does not replace employer tactics like reference-based pricing, centers-of-excellence networks, or direct contracting, it provides a structural backstop that reduces the bargaining imbalance between employers and consolidated provider systems, making every other cost-management strategy more effective over time.

## Cost Containment Strategy Comparison

| Strategy | Primary cost lever | Employer verdict |
| --- | --- | --- |
| Standalone PBM contract tuning | Rebates, formulary, network pharmacy terms | Useful for drug spend but limited against specialty and cell-and-gene therapies and total claims trend |
| Direct provider or center-of-excellence contracting | Bundled prices, site-of-care steering, warranty agreements | Strong for high-cost procedures; requires volume and referral control |
| Care coordination and navigation | Avoided complications, appropriate site and ER use, adherence | Best paired with claims data; reduces avoidable utilization but not unit prices alone |
| Self-funding with stop-loss | Transparency, plan design, vendor accountability | Gives employers leverage but exposes volatility; stop-loss and gene-therapy risk need management |

 Employers rarely contain costs with one lever. PBM negotiations help drug margins, direct contracting attacks high-ticket procedures, and care coordination reduces avoidable utilization; self-funding supplies data and control but adds volatility. The practical answer is an integrated program that measures total cost of care, not just vendor rebates. hcco.app supports payer and provider operations with B2B cost-containment and care-coordination workflows.

## Quick answers

### What are the primary drivers of rising healthcare costs?

Rising costs are driven by expensive specialty drugs, aging populations, and administrative inefficiencies across the healthcare system.

### How do PBMs help reduce employer drug costs?

PBMs negotiate rebates and discounts with manufacturers to lower the net price employers pay for prescription medications.

### What is payment integrity in healthcare?

Payment integrity involves auditing claims to ensure accurate pricing and identifying billing errors or overpayments before they are processed.

### Why are out-of-network claims a concern?

Out-of-network claims often lack negotiated rates, leading to higher charges and unexpected balance bills for employers and patients.

Canonical: https://hcco.app/knowledge/how_do_employers_manage_rising_healthcare_costs.php
Markdown: https://hcco.app/knowledge/how_do_employers_manage_rising_healthcare_costs.php/index.md
